Remedy Robotics raises $62M Series B for AI-enabled endovascular robot
Remedy Robotics, which develops robotic systems for cardiovascular care and endovascular procedures, has raised $62 million in Series B funding led by DCVC, the company said in a press release. New investors include UC Investments, the University of California's investment office, Skip Capital and Australian pension fund Hostplus, and existing investors including Tony Fadell's Build Collective and Blackbird added to their stakes.
Remedy is finalising its N1 System, an AI-enabled robotic platform that uses machine learning to analyse preoperative imaging, simulate cases in advance and complete entire endovascular procedures robotically, on site, remotely or autonomously. The company says it works with more than 100 hospitals and completed the world's first remote neurointerventional procedures with the system in October 2025.
The money will fund a planned pivotal clinical trial with the University of California, work toward FDA approval for neurovascular intervention, and deployment of prototype N1 Systems with clinical partners including SVIN Mission Thrombectomy and the Australian Stroke Alliance. "This funding will allow us to accelerate toward deployment of our N1 System," said CEO and co-founder Dr. David Bell.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Robotics Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Robotics
Nov 16 Pony.ai and Toyota put bZ4X robotaxi into fully driverless paid service in Guangzhou Nov 15 Tesla offers select customers a Cybercab for personal use at $29,990 plus $299 a month Nov 14 Military humanoid robot maker Foundation misses payroll after CEO borrowed $4.6 million, CNBC reports Nov 13 Ex-Cainiao CTO's robot startup worked Double 11 warehouses, claims nearly 5,000 orders Nov 13 OpenAI disbands its robotics team as general models start running robotsMore from Life Sciences
Nov 16 Healthcare AI spending grew 2.5x to $3.7B in 2026, Menlo Ventures says Nov 16 Lumeris launches Tom Health to extend primary care with AI Nov 16 Flagship Pioneering commits £100M to London lab for AI-native companies Nov 16 Treat raises €3M pre-seed for AI-assisted intake in private healthcare Nov 16 Apple launches health AI study app with OpenEvidence for up to 200,000 US usersRobotics Brief
Weekly coverage of AI-driven robotics advances in industrial automation, autonomous vehicles, and robotic systems.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
Reliable Robotics Adds $115 Million to Series D
Adsilico Raises £10 Million for Virtual Medical Device Testing
Mosaic Raises $47M for Blood Vessel Surgery Robots
Agile Robots Raises $500 Million at $8.5 Billion Valuation
Qvyon launches with $8 million to test robots and self-driving systems in simulation
Daily AI Brief: the AI news that matters, in your inbox.